Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Naproxen, Excluding The Syrup Dosage Form (Atc Code According To Who: M01Ae02)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 18916190

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient naproxen, excluding the syrup form (ATC code according to WHO: M01AE02). The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. It should be noted that the purchase quantity is unkno

Mt Ref Id - 18916190

Deadline - Aug 31, 2026